- Honorary Doctor of Medicine (MD.PhD(hc.)), Executive Master of Business Administration (eMBA), Bachelor of Science in Clinical Biochemistry (B.Sc), University of Oulu, Finland
- Successful transfers of IVD-related IP and technology on the R2B and B2B basis, 2015-
- Consultations regarding point-of-care and molecular diagnostics markets and technologies, 2016-
- Overviews on the in-vitro diagnostic market to investors and investment banks, 2015-
- Board member of Faculty of Biochemistry and Molecular Medicine, University of Oulu, 2018-
- Program Director and Chief Financial Officer of the SalWe Intelligent Monitoring of Health and Well-being Program (€25M), 2010–2014; and CFO of the Mind and Body Program (€36M), 2012–2014
- Assistant Vice President of Orion Diagnostica Ltd, 1992–2012; several responsibilities, e.g. for R&D, new business development and partnerships in Finland, USA, Germany, France and Japan
- Co-founder and Chairman of the Finnish In Vitro Diagnostics Industry Cluster 1997-2017
- Clinical biochemist at the Hospital Laboratory of the Deaconess Institute, Oulu, 1970–1978
- Co-founder and Managing Director of a diagnostic company Nordiclab Ltd, Oulu, 1976–1982
- Director of the diagnostics plant of Farmos Diagnostica, Oulunsalo, 1982–1992
- Co-author of 25 scientific publications related to biochemical endocrinology and bone metabolism
- Co-inventor of a patent family related to the biochemical diagnostics of heart failure
- Co-author of a chapter in the book “Hormonal Therapies in Postmenopausal Osteoporosis” and author of an article in the book “Advances in Developing Affordable In Vitro Molecular Diagnostics”
- EU FP7, member of working group for “Detection, Diagnostics and Monitoring”